BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX)
TheFly reported on May 5 that IDXX saw its valuation outlook reduced as BofA Securities lowered its price target to $660 from $790 while maintaining a Neutral stance on the stock.







